Exponent’s Board of Directors increased the company’s share‑repurchase authorization by $100 million, raising the total available for buybacks to $121.6 million when combined with the $21.6 million already authorized.
The expansion gives Exponent greater flexibility to return capital to shareholders through share repurchases, complementing its long‑term dividend policy.
As of July 4 2025, Exponent held $231.8 million in cash and cash equivalents, down from $245.1 million at the end of Q1 2025 but up from $203.3 million at the end of H1 2024. Net income was $28 million in Q3 2025, up from $26 million in Q3 2024, while Q2 2025 net income of $26.6 million fell from $29.2 million in Q2 2024.
The company declared a quarterly dividend of $0.30 per share, payable December 19 2025, continuing a 12‑year streak of dividend increases.
Exponent’s engineering and scientific segment accounted for 84% of Q3 2025 revenues, driven by growth in data‑center and aerospace services. Management cited strong demand from data‑center clients and continued investment in high‑growth sectors as key drivers.
Exponent is returning to a 52‑week fiscal year in 2025, meaning fiscal 2024 benefited from a 53rd week and Q4 2025 will be a 13‑week quarter. The shift creates headwinds for full‑year and Q4 comparisons, but the company maintains guidance for 2025 earnings per share.
The increased authorization signals confidence in Exponent’s financial position and provides a tool to support shareholder value through a combination of dividends and share repurchases.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.